Health Management Is Shifting from Products to Individual Conditions

The focus of the health management market is rapidly moving from the sale of mass-market products to management services that reflect each person’s condition. The fact that group catering companies are operating blood sugar management programs bundled with apps and counseling, and have presented cases showing an average 13.2 mg/dL reduction in fasting blood glucose in just seven weeks, demonstrates that meals are being reinterpreted as health data-based services rather than merely a form of employee welfare.

This trend is also extending beyond health functional foods for humans into the companion animal sector. The reason pet dog products are becoming more specialized into categories such as joint, eye, coat, and stamina care is that family health-related spending is shifting toward disease prevention and everyday management. Going forward, service capabilities that combine analysis, counseling, and lifestyle records may become more important than the products themselves.

The Standard for Functional Competition Is Moving from Listing Ingredients to Securing Evidence

Health functional food companies are now going beyond simply adding trendy ingredients and are differentiating themselves by securing individually approved ingredients and conducting human application trials. The reason they are investing in research and development to obtain permitted functional claims such as may help reduce body fat or may help improve blood circulation by inhibiting platelet aggregation is that, in a market where regulations are tightening, scientific evidence directly affects pricing power and negotiating leverage with distributors.

In the same context, the expansion of academic paper contests and regulatory improvements for customized health functional foods are also reshaping the foundation of the industry. From the companies’ perspective, data and standards have become more important than marketing phrases, while from the consumers’ perspective, it is becoming easier to distinguish the scope and limitations of functional claims more clearly. As a result, the market is gradually being reorganized into a more research-centered structure.

Regional Hubs Attracting Factory and Workforce Investment

At industrial sites, there is a clear movement to build production bases and workforce training systems at the regional level in line with growing demand. Under a plan to invest a total of about 2.4 trillion won in the Gangwon specialized complex, practical training for a total of 19 people has begun, and in Gyeongsan, an integrated plant built with an investment of more than 25 billion won has started operations. This indicates that the health functional food and bio industries are moving from the laboratory stage into an actual manufacturing ecosystem.

However, not all companies are increasing their production bases. Some are instead choosing to streamline existing facilities, as in the sale of a health functional food plant in Anseong, and concentrate volume at core factories to improve efficiency. This means that even though the market is growing, it has entered a stage where profitability, quality control, and supply stability are being weighed alongside expansion in scale.

Tighter Regulation and Stronger Consumer Protection to Curb Exaggerated Advertising

As market segmentation and rapid growth continue, exaggerated advertising and consumer confusion are also increasing, prompting tighter regulation. The fact that 26 companies were caught for making food products appear to be obesity treatments or promoting cosmetics as if they had therapeutic effects, with about 11.5 billion won in sales confirmed, shows the reality that sales competition often crosses legal boundaries.

For this reason, authorities are pursuing not only stricter enforcement of labeling and advertising rules but also systems for consumer redress and the provision of age-specific safety information. Ultimately, the market’s next competition is likely to shift from how sensational a product appears to whether companies can clearly present legal classifications and levels of evidence while still securing consumer trust.